Universal Pictures’ newest horror entry, Other Mommy entered more than 3,300 North American theaters this weekend and generated an impressive $27.5 million in its opening span. The film, starring Jessica Chastain as a nightmarish doppelgänger, has been lambasted by critics – it carries a 19% rating on Rotten Tomatoes and a dismal D+ from CinemaScore – yet the numbers suggest that the genre’s loyal fan base remains largely unfazed by bad press. With a production budget reported near $19 million the movie already eclipses its cost and joins a string of recent Blumhouse-backed successes that prove low-budget fright can dominate the market.
Audience demographics and international rollout
Jim Orr, head of domestic distribution at Universal, emphasized that the opening crowd was split evenly between male and female viewers, with roughly two-thirds falling in the 18-34 age bracket. “When a film attracts such a broad cross-section, it usually signals staying power,” Orr noted. Beyond the United States, Other Mommy debuted in 50 foreign markets, adding about $17.7 million to its global total and pushing the worldwide figure to just over $45 million. The international response mirrors the domestic trend: horror remains a universally marketable genre, especially when backed by a recognizable star.
Social Reckoning’s muted debut
In stark contrast, Sony Pictures’ The Social Reckoning opened in 2,606 U.S. venues and mustered only $5.5 million. The film, written and directed by Aaron Sorkin dramatizes a fictional Facebook whistleblower and stars Mikey MadisonJeremy Allen White and Jeremy Strong. Early audience polling granted it a B- CinemaScore, but critics remain split, reflected in a 54% Rotten Tomatoes approval. At a reported production cost of $30 million the opening falls short of the studio’s modest expectations of $7-$8 million and raises concerns about the film’s ability to recoup its investment.
The movie’s underperformance also highlights a broader shift in audience appetite. While the original 2010 The Social Network debuted with $22 million and ultimately amassed $224 million worldwide, the sequel-in-spirit lacks the cultural moment that propelled its predecessor. Moreover, the R-rated thriller failed to ignite the older-male demographic that typically fuels tech-drama ticket sales, a group still hesitant to return to cinemas after the pandemic era.
Weekend box-office landscape and ancillary releases
Other titles rounded out the top ten. Anne Hathaway’s psychological thriller Verity slipped to second place with $11.5 million, a 64% drop from its opening. The revived Resident Evil franchise held third at $8.4 million, while Brad Pitt’s survival drama Heart of the Beast earned $7.1 million. Christopher Nolan’s The Odyssey continues its marathon run, adding $2 million in its 13th weekend across 560 theaters, nudging its domestic total toward $623 million.
Limited-release specialty films also made modest dents: the Cannes Palme d’Or winner Fjord opened on four screens for $124,000, Alex Gibney’s four-hour documentary Musk collected $68,900, and Chris Rock’s directorial effort Misty Green garnered $85,716. These titles aim for awards buzz rather than mass-market revenue, and their early figures will be monitored as the awards season approaches.
Yet October remains a testing ground for riskier projects, and the divergent fortunes of Other Mommy and The Social Reckoning illustrate how genre loyalty can outweigh critical reception, while prestige-driven dramas may struggle without a clear cultural hook.
